Both in Biotechnology
Vaxcyte vs Bio-Techne
Over the past year PCVX returned +41.5% and TECH returned +18.6%; their daily moves had a correlation of 0.04.
PCVX +41.5% TECH +18.6%Growth of $1, one year, split-adjusted
| Metric | PCVX | TECH |
|---|---|---|
| Price | $60.62 | $72.67 |
| Market cap | $9.54B | $11.41B |
| Today | −2.27% | +0.01% |
| 1 month | +7.3% | +0.4% |
| 6 months | +3.6% | +32.8% |
| Year to date | +31.4% | +23.6% |
| 1 year | +35.5% | +19.2% |
| Revenue growth (YoY) | — | +1.3% |
| Gross margin | — | 65.8% |
| Net margin | — | 17.0% |
| P/E (TTM) | — | 62.8× |
| Price / sales | — | 9.4× |
| Net cash | $1.49B | $64.7M |
| Dividend yield | — | 0.44% |
| Volatility (60d) | 70.6% | 2.2% |
| Short % of float | 11.2% | 4.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).